Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

908 Devices (MASS) Cash & Equivalents (2020 - 2025)

908 Devices (MASS) has disclosed Cash & Equivalents for 6 consecutive years, with $70.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 60.15% to $70.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $70.5 million, a 60.15% increase, with the full-year FY2025 number at $70.5 million, up 60.15% from a year prior.
  • Cash & Equivalents was $70.5 million for Q4 2025 at 908 Devices, up from $62.8 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $224.1 million in Q4 2021 to a low of $44.0 million in Q4 2024.
  • A 5-year average of $126.0 million and a median of $127.0 million in 2023 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: soared 1146.7% in 2021, then crashed 64.8% in 2024.
  • 908 Devices' Cash & Equivalents stood at $224.1 million in 2021, then dropped by 15.91% to $188.4 million in 2022, then tumbled by 35.76% to $121.0 million in 2023, then crashed by 63.62% to $44.0 million in 2024, then surged by 60.15% to $70.5 million in 2025.
  • Per Business Quant, the three most recent readings for MASS's Cash & Equivalents are $70.5 million (Q4 2025), $62.8 million (Q3 2025), and $61.8 million (Q2 2025).